How often should you bathe your child with eczema? Daily ‘soak and smear’ or steer clear?
If you have a child with newly-diagnosed eczema, you may be wondering how often you should bathe him. You are not alone.
Category Archives: Eczema / Psoriasis
Possible psoriasis drug target identified by Stanford researchers
Psoriasis is one of the most common human skin diseases. People with severe cases sometimes resort to immunosuppressive treatment to quell the skin scaling, itching and joint arthritis that are...
New drug clears psoriasis in clinical trials
About 80 percent of patients with moderate to severe psoriasis saw their disease completely or almost completely cleared with a new drug called ixekizumab, according to three large, long-term...
Stem cells from umbilical cord blood may help treat eczema
A new study suggests that treatment with stem cells from umbilical cord blood might be an effective therapy for patients with moderate-to-severe eczema, or atopic dermatitis.
Atopic dermatitis: Positive topline Phase 3 results announced for dupilumab
Regeneron Pharmaceuticals, Inc. and Sanofi have announced that a one-year Phase 3 study, known as LIBERTY AD CHRONOS, evaluating investigational dupilumab met its primary and key secondary...
Positive results announced for two pivotal Phase-3 clinical trials of tildrakizumab in patients with moderate-to-severe plaque psoriasis
Sun Pharma has announced that two pivotal Phase-3 clinical trials evaluating the efficacy and safety of the investigational IL-23p19 inhibitor antibody tildrakizumab (MK-3222) in patients with...
Research finds that itch drives those with psoriasis ‘mad’ yet nearly half do not discuss itch with their doctor
New discussion tool launched to aid.Research funded by Celgene in collaboration with the Psoriasis Association reveals the extent to which itch, often an under-rated symptom of psoriasis...
Research opens new treatment strategies for specific form of psoriasis
Psoriasis is a long-lasting autoimmune disease that is characterized by patches of abnormal and inflamed skin.
Positive dupilumab topline results announced from two Phase 3 trials in inadequately controlled moderate-to-severe atopic dermatitis patients
Regeneron Pharmaceuticals, Inc. and Sanofi have announced that two placebo-controlled Phase 3 studies evaluating investigational dupilumab in adult patients with inadequately controlled...
FDA approves new psoriasis drug Taltz
The U.S. Food and Drug Administration has approved Taltz (ixekizumab) to treat adults with moderate-to-severe plaque psoriasis.